Related Experiment Video

Updated: Jul 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Management of antiplatelet therapy for minimization of bleeding risk before cardiac surgery

Kyle A Weant1, Jeremy F Flynn, Wendell S Akers

  • 1University of North Carolina Hospitals and the School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.

Pharmacotherapy
|October 27, 2006
PubMed

Insights

Managing antiplatelet therapy is crucial for preventing cardiovascular events like stroke and heart attack, but it increases bleeding risk. Optimizing this therapy in patients undergoing coronary artery bypass graft surgery requires balancing these risks.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Surgical Management

Background:

  • Antiplatelet therapy is standard for preventing thrombotic events such as stroke, myocardial infarction, and angina.
  • These therapies significantly increase the risk of bleeding complications.
  • Coronary artery bypass graft (CABG) surgery presents unique challenges for managing antiplatelet agents.

Purpose of the Study:

  • To outline the management strategies for antiplatelet therapy in patients undergoing CABG surgery.
  • To elucidate the mechanisms of action for common antiplatelet agents.
  • To integrate pharmacokinetic, pharmacodynamic, and clinical trial data for informed decision-making.

Main Methods:

  • Review of pharmacologic studies and clinical trials on antiplatelet agents.
  • Analysis of drug mechanisms, pharmacokinetics, and pharmacodynamics.
  • Assessment of clinical efficacy and risk-benefit profiles in the context of CABG.

Main Results:

  • Common antiplatelet agents inhibit platelet aggregation through various mechanisms.
  • Balancing antithrombotic benefits against bleeding risks is essential in CABG patients.
  • Individual patient risk stratification for thrombosis versus hemorrhage is critical.

Conclusions:

  • Effective management of antiplatelet therapy in CABG patients necessitates a comprehensive understanding of drug properties and patient-specific risks.
  • Personalized treatment strategies are required to optimize outcomes and minimize complications.
  • Further research integrating pharmacokinetic and clinical data can refine antiplatelet management protocols.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...